PT-141 is another name commonly used for bremelanotide, a melanocortin receptor agonist. Unlike many peptides marketed by wellness clinics, bremelanotide has an FDA-approved prescription product: Vyleesi.
What Is PT-141 / Bremelanotide?
Bremelanotide is a synthetic cyclic peptide that acts on melanocortin receptors. It does not replace estrogen, testosterone or another sex hormone directly.
What Is Vyleesi FDA Approved For?
FDA approved Vyleesi (bremelanotide injection) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) that causes marked distress or interpersonal difficulty and is not due to another medical or psychiatric condition, relationship problems, or medication or drug effects.
The FDA-approved indication does not include postmenopausal women or men, and Vyleesi is not approved simply to enhance sexual performance.
PT-141 and Hormone Replacement Therapy Are Different
Bremelanotide acts through melanocortin signaling rather than replacing estrogen or testosterone. A woman with low sexual desire may need evaluation for relationship factors, medication effects, mood disorders, pain with sex, genitourinary syndrome of menopause, menopause symptoms, thyroid disease or other medical causes before treatment is selected.
What Are the Main Safety Considerations?
Prescription bremelanotide has labeled warnings and adverse-effect considerations. Treatment decisions should be based on the current prescribing information, cardiovascular risk, medication history and whether the patient actually meets the approved clinical indication.
What About PT-141 Nasal Sprays or Products Sold Online?
An online product marketed as PT-141 should not be assumed to be equivalent to an FDA-approved prescription product. Route, formulation, identity, potency, purity and sterility matter. Products sold for “research use” are not approved for human treatment.
PT-141 Near Me: What Should You Look For?
Patients searching for PT-141 near me or a peptide clinic should look for a clinician who evaluates the cause of sexual symptoms, explains whether the product is FDA approved for the proposed use, reviews contraindications and alternatives, and uses appropriate follow-up rather than treating PT-141 as a general libido enhancer.
Related Women’s Hormone Resources
Learn more about testosterone in women, GSM and vaginal atrophy, and peptide therapy in Los Angeles.
